How much does Dasatinib cost?

Dasatinib (Dasatinib) is an oral, short-acting inhibitor of multiple tyrosine kinases. It was designed to inhibit ABL and SRC, but is also active in a variety of other kinases, including c-KIT, PDGFR-α, PDGFP-β, and adrenergic receptor kinase.

Dasatinib is a highly potent inhibitor of BCR-ABL and is an effective treatment for the BCR-ABL driven diseases chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), characterized by the constitutively active tyrosine kinase BCR-ABL. Dasatinib is approved for the treatment of chronic myelogenous leukemia (all stages), including in children, and for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior imatinib therapy. Common side effects include infection, bone marrow suppression, headache, bleeding, pleural effusion, dyspnea, diarrhea, vomiting, nausea, abdominal pain, rash, musculoskeletal pain, fatigue, leg and arm and facial swelling, and fever

The original drug of dasatinib has been launched in China and is included in the medical insurance. Currently, reimbursement is only available to eligible patients. Common specifications The price of each box of 50mg*60 tablets may be around RMB 10,000. The original drug overseas is even more expensive. Dasatinib generics are also sold overseas. The ingredients of the drug are basically the same as those sold domestically and abroad, but the price is cheaper. For example, the price of 50mg*60 tablets per box produced by an Indian pharmaceutical factory may be RMB 500 (the price may fluctuate due to exchange rates).